Skip to main content

Dake Benjamin T's Form 4 filing

Jade Biosciences, Inc. (JBIO) · filed Jul 7, 2023

Accession no.
0001415889-23-010966
Filed
Jul 7, 2023
Trade date
Jul 6, 2023
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 4 derivative transactions. Open-market sales total $171.3K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Dake Benjamin TCIK 0001869248Officer (SEE REMARKS)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 6, 2023Common StockMOption exerciseAcquired+2,412$1.74+$4,196.883,703Direct
Jul 6, 2023Common StockMOption exerciseAcquired+7,871$2.14+$16,843.9411,574Direct
Jul 6, 2023Common StockSSaleDisposed−10,283$16.66−$171,314.781,291Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 6, 2023Common StockMOption exerciseDisposed−906$0.00$05,433Direct
Jul 6, 2023Common StockMOption exerciseDisposed−1,506$0.00$019,589Direct
Jul 6, 2023Common StockMOption exerciseDisposed−1,019$0.00$021,386Direct
Jul 6, 2023Common StockMOption exerciseDisposed−6,852$0.00$0157,609Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)